Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IBA GO_REF:0000033	ACCEPT	Summary: Core molecular function of NEUROG1 as a bHLH transcription factor that binds DNA and activates transcription of neuronal differentiation genes. Reason: This is a core molecular function of NEUROG1. The protein functions as an RNA polymerase II-specific transcription factor. Strong experimental support exists (IDA, TAS evidence) and phylogenetic inference is appropriate for this well-conserved function among bHLH factors. Supporting Evidence: PMID:8816493 neuroD3 is expressed transiently during embryonic development [...] Similar to neuroD, expression of neuroD2 in developing Xenopus laevis embryos results in ectopic neurogenesis, indicating that neuroD2 mediates neuronal differentiation. Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs file:human/NEUROG1/NEUROG1-deep-research-falcon.md model: Edison Scientific Literature
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	ISA GO_REF:0000113	ACCEPT	Summary: Duplicate of IBA annotation above. TFClass database confirms NEUROG1 as a class 1.2.3 bHLH transcription factor. Reason: Acceptable duplicate with ISA evidence from TFClass database, which systematically classifies transcription factors. No action needed as duplicates with different evidence codes are permitted.
GO:0070888 E-box binding	IBA GO_REF:0000033	ACCEPT	Summary: Core DNA-binding specificity. NEUROG1 binds to E-box motifs (CANNTG) as a heterodimer with E-proteins. Reason: E-box binding is the specific DNA-binding activity of NEUROG1 and all neurogenin family members. This is more informative than generic "DNA binding" and represents the core molecular function by which NEUROG1 activates target genes. Supporting Evidence: PMID:20102160 Upon binding to two DNA E-boxes, the protein forms "fuzzy" complexes (that is, the complexes were not fully folded).
GO:0070888 E-box binding	IEA GO_REF:0000107	ACCEPT	Summary: Duplicate E-box binding annotation via Ensembl orthology transfer. Reason: Acceptable duplicate annotation with computational evidence from mouse ortholog.
GO:0070888 E-box binding	IDA PMID:20102160 The basic helix-loop-helix region of human neurogenin 1 is a...	ACCEPT	Summary: Direct experimental demonstration of E-box binding activity. Reason: Strongest evidence type (IDA) for E-box binding from biochemical studies. This annotation provides experimental validation of the IBA and computational predictions. Supporting Evidence: PMID:20102160 Upon binding to two DNA E-boxes, the protein forms "fuzzy" complexes (that is, the complexes were not fully folded). The affinities of bHLHN for both DNA boxes were smaller than those of other bHLH domains
GO:0070888 E-box binding	ISS GO_REF:0000024	ACCEPT	Summary: E-box binding inferred from mouse ortholog. Reason: Acceptable sequence similarity-based inference. Consistent with experimental evidence.
GO:1990837 sequence-specific double-stranded DNA binding	IEA GO_REF:0000117	ACCEPT	Summary: Computational annotation for sequence-specific DNA binding by ARBA rules. Reason: Accurate representation of NEUROG1's DNA-binding properties. NEUROG1 binds specific E-box sequences, not generic DNA. Supported by experimental evidence from other annotations.
GO:1990837 sequence-specific double-stranded DNA binding	IDA PMID:28473536 Impact of cytosine methylation on DNA binding specificities ...	ACCEPT	Summary: Direct experimental evidence for sequence-specific DNA binding in context of DNA methylation study. Reason: IDA evidence from systematic study of transcription factor DNA-binding specificities. Confirms sequence-specific binding property. Supporting Evidence: PMID:28473536 Impact of cytosine methylation on DNA binding specificities of human transcription factors.
GO:1990837 sequence-specific double-stranded DNA binding	IDA PMID:20102160 The basic helix-loop-helix region of human neurogenin 1 is a...	ACCEPT	Summary: Direct demonstration of sequence-specific DNA binding to E-box elements. Reason: Strong experimental evidence (IDA) from biochemical characterization of NEUROG1 bHLH domain binding to specific DNA sequences. Supporting Evidence: PMID:20102160 Upon binding to two DNA E-boxes, the protein forms "fuzzy" complexes
GO:0003677 DNA binding	IEA GO_REF:0000043	ACCEPT	Summary: Generic DNA binding annotation from UniProtKB keyword mapping. Reason: While this term is less informative than the more specific E-box binding and sequence-specific DNA binding terms, it is technically correct and derives from automated keyword mapping. The more specific terms already capture the functional detail.
GO:0003677 DNA binding	EXP PMID:20102160 The basic helix-loop-helix region of human neurogenin 1 is a...	ACCEPT	Summary: Experimental evidence for DNA binding from biochemical studies. Reason: Acceptable experimental evidence, though the more specific terms (E-box binding, sequence-specific DNA binding) better capture NEUROG1's function. This provides a valid, albeit broad, characterization. Supporting Evidence: PMID:20102160 Upon binding to two DNA E-boxes, the protein forms "fuzzy" complexes
GO:0003700 DNA-binding transcription factor activity	TAS PMID:8816493 NeuroD2 and neuroD3 - distinct expression patterns and trans...	ACCEPT	Summary: Traceable author statement establishing NEUROG1 as a transcription factor with neurogenic activity. Reason: Valid TAS evidence from the original characterization paper. While GO:0000981 (RNA pol II-specific) is more precise, this broader term is acceptable given the strong literature support. Supporting Evidence: PMID:8816493 We have identified two new genes, neuroD2 and neuroD3, on the basis of their similarity to the neurogenic basic-helix-loop-helix (bHLH) gene neuroD [...] Similar to neuroD, expression of neuroD2 in developing Xenopus laevis embryos results in ectopic neurogenesis
GO:0003682 chromatin binding	IEA GO_REF:0000107	ACCEPT	Summary: Chromatin binding inferred from mouse ortholog via Ensembl Compara. Reason: Biologically plausible and consistent with UniProtKB annotation stating NEUROG1 "Associates with chromatin to enhancer regulatory elements." Transcription factors must access chromatinized DNA templates.
GO:0003682 chromatin binding	ISS GO_REF:0000024	ACCEPT	Summary: Chromatin binding inferred by sequence similarity to mouse ortholog. Reason: Acceptable ISS inference. Supported by UniProtKB functional annotation describing chromatin association.
GO:0046983 protein dimerization activity	IEA GO_REF:0000002	ACCEPT	Summary: Protein dimerization activity inferred from InterPro bHLH domain (IPR011598, IPR036638). Reason: Accurate inference from domain composition. bHLH proteins require dimerization for DNA binding. NEUROG1 forms heterodimers with E-proteins (TCF4/E12) as documented in UniProtKB and literature.
GO:0042803 protein homodimerization activity	IDA PMID:20102160 The basic helix-loop-helix region of human neurogenin 1 is a...	ACCEPT	Summary: Direct experimental evidence that NEUROG1 bHLH domain can homodimerize. Reason: Legitimate experimental observation from biochemical studies. However, note that in vivo, NEUROG1 primarily functions as a heterodimer with E-proteins (TCF4/E12), not as a homodimer. The homodimerization activity is real but may not reflect the physiologically relevant state. Supporting Evidence: PMID:20102160 The basic helix-loop-helix region of human neurogenin 1 is a monomeric natively unfolded protein which forms a "fuzzy" complex upon DNA binding.
GO:0005515 protein binding	IPI PMID:25416956 A proteome-scale map of the human interactome network	REMOVE	Summary: Generic protein binding from proteome-scale interactome study (interaction with TCF4/P15884). Reason: Per curation guidelines, "protein binding" should be removed as it is uninformative. The specific interaction with TCF4 (E-protein heterodimerization partner) is biologically relevant but should be captured with a more specific molecular function term if available. The heterodimerization is already captured by GO:0046983 (protein dimerization activity). Supporting Evidence: PMID:25416956 A proteome-scale map of the human interactome network.
GO:0005515 protein binding	IPI PMID:32296183 A reference map of the human binary protein interactome	REMOVE	Summary: Generic protein binding from binary interactome study (interaction with TCF12/Q99081-3). Reason: Per curation guidelines, remove uninformative "protein binding" term. TCF12 is another E-protein heterodimerization partner, already captured conceptually by dimerization activity terms. Supporting Evidence: PMID:32296183 Apr 8. A reference map of the human binary protein interactome.
GO:0005515 protein binding	IPI PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ...	REMOVE	Summary: Generic protein binding from neurodegenerative disease interactome study. Reason: Uninformative per guidelines. Remove generic protein binding annotation. Supporting Evidence: PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
GO:0005515 protein binding	IPI PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling...	REMOVE	Summary: Generic protein binding from cell-specific interactome remodeling study. Reason: Uninformative per guidelines. Remove generic protein binding annotation. Supporting Evidence: PMID:33961781 2021 May 6. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005515 protein binding	IPI PMID:40205054 Multimodal cell maps as a foundation for structural and func...	REMOVE	Summary: Generic protein binding from multimodal cell atlas study. Reason: Uninformative per guidelines. Remove generic protein binding annotation. Supporting Evidence: PMID:40205054 Apr 9. Multimodal cell maps as a foundation for structural and functional genomics.
GO:0005634 nucleus	IBA GO_REF:0000033	ACCEPT	Summary: Nuclear localization inferred by phylogenetic analysis across bHLH transcription factor family. Reason: Correct subcellular localization. NEUROG1 is a nuclear transcription factor as confirmed by UniProtKB annotation and expected for its function.
GO:0005634 nucleus	IEA GO_REF:0000044	ACCEPT	Summary: Nuclear localization from UniProtKB subcellular location vocabulary mapping. Reason: Acceptable duplicate annotation via automated mapping. Consistent with protein function and other evidence.
GO:0000785 chromatin	ISA GO_REF:0000113	ACCEPT	Summary: Chromatin localization from TFClass database annotation of sequence-specific DNA-binding transcription factors. Reason: Appropriate for a transcription factor that must access chromatinized DNA. Supported by UniProtKB statement that NEUROG1 "Associates with chromatin to enhancer regulatory elements."
GO:0043025 neuronal cell body	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Neuronal cell body localization inferred from mouse ortholog. Reason: While NEUROG1 is expressed in neural progenitors and developing neurons, this is not a primary defining feature of the protein. The nuclear localization is more fundamental. However, this annotation may reflect expression data from mature neurons and is acceptable as a non-core annotation documenting tissue/cell-type expression context.
GO:0043204 perikaryon	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Perikaryon (neuronal cell body) localization from mouse ortholog. Reason: Perikaryon is essentially synonymous with neuronal cell body (GO:0043025). This annotation reflects expression context rather than core function. Acceptable as non-core documentation of where NEUROG1 is found in differentiated neurons, though its key developmental role is in progenitors.
GO:0045666 positive regulation of neuron differentiation	IEA GO_REF:0000107	ACCEPT	Summary: Positive regulation of neuron differentiation from mouse ortholog. Reason: Core function of NEUROG1 as a proneural transcription factor. This regulatory term accurately captures that NEUROG1 promotes/activates neuronal differentiation programs. Supporting Evidence: PMID:8816493 Similar to neuroD, expression of neuroD2 in developing Xenopus laevis embryos results in ectopic neurogenesis, indicating that neuroD2 mediates neuronal differentiation
GO:0045666 positive regulation of neuron differentiation	ISS GO_REF:0000024	ACCEPT	Summary: Duplicate annotation via sequence similarity to mouse ortholog. Reason: Acceptable duplicate with ISS evidence. Consistent with IEA annotation above and experimental literature.
GO:0045944 positive regulation of transcription by RNA polymerase II	IBA GO_REF:0000033	ACCEPT	Summary: Transcriptional activation function inferred by phylogenetic analysis. Reason: Accurate mechanistic description of how NEUROG1 functions - it activates transcription of target genes. This is the molecular mechanism underlying its role in neuron differentiation. Supporting Evidence: PMID:8816493 Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs
GO:0045944 positive regulation of transcription by RNA polymerase II	IEA GO_REF:0000107	ACCEPT	Summary: Duplicate transcriptional activation annotation from mouse ortholog. Reason: Acceptable duplicate via orthology transfer.
GO:0045944 positive regulation of transcription by RNA polymerase II	ISS GO_REF:0000024	ACCEPT	Summary: Transcriptional activation inferred by sequence similarity. Reason: Acceptable duplicate with ISS evidence.
GO:0006357 regulation of transcription by RNA polymerase II	TAS PMID:8816493 NeuroD2 and neuroD3 - distinct expression patterns and trans...	ACCEPT	Summary: Traceable author statement for transcriptional regulation function. Reason: Valid TAS evidence from original characterization. The more specific "positive regulation" term (GO:0045944) is preferable, but this broader term is acceptable and accurately describes NEUROG1's mechanism of action. Supporting Evidence: PMID:8816493 Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs and can activate a reporter driven by the neuroD2 promoter region
GO:0007399 nervous system development	IEA GO_REF:0000043	ACCEPT	Summary: General nervous system development from UniProtKB keyword. Reason: Accurate broad characterization. NEUROG1 plays essential roles in nervous system development, particularly in cranial sensory ganglia formation and cortical neurogenesis. More specific terms (sensory organ development, cranial nerve development) provide additional detail.
GO:0007399 nervous system development	TAS PMID:8816493 NeuroD2 and neuroD3 - distinct expression patterns and trans...	ACCEPT	Summary: Traceable author statement for nervous system development role from original characterization paper. Reason: Valid TAS evidence demonstrating NEUROG1's neurogenic function. Supporting Evidence: PMID:8816493 neuroD3 is expressed transiently during embryonic development, with the highest levels of expression between days 10 and 12
GO:0030154 cell differentiation	IEA GO_REF:0000043	ACCEPT	Summary: Generic cell differentiation term from keyword mapping. Reason: While very broad, this is technically accurate - NEUROG1 drives cell differentiation (specifically neuronal differentiation). The more specific neuron differentiation term (GO:0030182) is more informative, but this general term is acceptable.
GO:0061564 axon development	IBA GO_REF:0000033	KEEP AS NON CORE	Summary: Axon development inferred by phylogenetic analysis across neurogenin orthologs. Reason: NEUROG1 is expressed in neural progenitors and early differentiating neurons. While NEUROG1-expressing cells will eventually develop axons, axon development is a later differentiation event. This may represent over-annotation or propagation from species where neurogenins have been studied in axonal contexts. Mark as non-core since NEUROG1's primary function is fate commitment and early differentiation, not axon morphogenesis per se.
GO:0007423 sensory organ development	IBA GO_REF:0000033	ACCEPT	Summary: Sensory organ development inferred across neurogenin family members. Reason: Accurate and well-supported. NEUROG1 is essential for development of cranial sensory ganglia (trigeminal, vestibulocochlear). Loss of NEUROG1 causes profound defects in sensory organ development (inner ear, sensory nerve formation). This is a core developmental function. Supporting Evidence: PMID:23419067 The neurog1 protein was found to be essential for the development of proximal sensory ganglia and for neurons forming from the trigeminal and otic placodes [8]
GO:0030900 forebrain development	IBA GO_REF:0000033	KEEP AS NON CORE	Summary: Forebrain development inferred from limited phylogenetic support (only 3 orthologs in WITH/FROM field). Reason: NEUROG1 is expressed in forebrain progenitors and contributes to cortical neurogenesis. However, this is one of multiple regional contexts for NEUROG1 function (also hindbrain, cranial ganglia). The IBA evidence is weak (only 3 supporting orthologs suggests limited phylogenetic support). Mark as non-core since forebrain is one developmental context but not the defining feature of NEUROG1's function.
GO:0021559 trigeminal nerve development	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Trigeminal nerve (CN V) development demonstrated by genetic interaction evidence from human NEUROG1 deletion patient. Reason: Strong genetic evidence from human patient with homozygous NEUROG1 deletion showing severe oral motor dysfunction due to trigeminal nerve defects. This is a core developmental function of NEUROG1 in cranial sensory neuron specification. Supporting Evidence: PMID:23419067 The boy was unable to swallow and to chew food and showed increased salivation and speech difficulties [...] Correspondingly, we assume a malfunction of the Vth cranial nerve in the boy that could be caused by lack of sensory innervation or a missing motor innervation [...] Neurog1 is a neuronal determination gene for the cranial sensory neurons that give rise to cranial nerves V and VIII
GO:0021650 vestibulocochlear nerve formation	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Vestibulocochlear nerve (CN VIII) formation demonstrated by genetic interaction from human deletion patient. Reason: Strong genetic evidence. The patient had truncation/aplasia of CN VIII, profound deafness, and balance disorder. CN VIII development is a core function of NEUROG1 in otic placode-derived sensory neurons. Supporting Evidence: PMID:23419067 truncation or severe hypoplasia of the vestibulo-cochlear (VIIIth cranial) nerve. In the neurog1−/− mouse embryos, similar malformations of peripheral neural structures with absence of the vestibular-cochlear ganglion and of all afferent, efferent, and autonomic nerve fibers of the VIIIth cranial nerve were reported
GO:0048839 inner ear development	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Inner ear development defects in NEUROG1 deletion patient. Reason: Well-supported by genetic evidence. The patient had cochlear hypoplasia and inner ear malformations. NEUROG1 is essential for otic placode-derived neuronal development, which is critical for inner ear innervation and development. Supporting Evidence: PMID:23419067 the inner ear showed an overall reduction in size and the cochlea only had 1.25 turns, as opposed to 1.75 turns in the control littermates [...] the vestibulo-cochlear system of the neurog1−/− mutant mice showed a distinct missing utriculosaccular duct with only a small saccular recess
GO:0042472 inner ear morphogenesis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Inner ear morphogenesis defects with specific cochlear and vestibular malformations. Reason: More specific than "inner ear development" - focuses on morphogenetic defects. Well-supported by detailed anatomical descriptions in PMID:23419067. Acceptable as it captures the structural malformations resulting from NEUROG1 loss. Supporting Evidence: PMID:23419067 The boy's internal auditory canal was narrowed and the cochlea was hypoplastic with only one single widened cochlear turn
GO:0090102 cochlea development	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Cochlea development defects in NEUROG1-deleted patient. Reason: Specific cochlear malformations documented. Acceptable as more specific characterization of inner ear phenotype. Supporting Evidence: PMID:23419067 the cochlea was hypoplastic with only one single widened cochlear turn
GO:0090103 cochlea morphogenesis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	ACCEPT	Summary: Cochlea morphogenesis defects showing structural malformations. Reason: Captures specific morphogenetic defects in cochlear structure. Supported by anatomical descriptions. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0031223 auditory behavior	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	KEEP AS NON CORE	Summary: Profound deafness and auditory defects in NEUROG1 deletion patient. Reason: The deafness is a secondary consequence of CN VIII aplasia and inner ear malformation, not a direct function of NEUROG1. NEUROG1's core function is neuronal specification in the otic placode; the auditory behavior defect is a downstream phenotypic consequence. Mark as non-core to distinguish developmental function from behavioral outcome. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0050885 neuromuscular process controlling balance	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	KEEP AS NON CORE	Summary: Balance disorder in patient due to vestibular nerve and inner ear defects. Reason: Balance defects are secondary to vestibular apparatus and nerve malformation, not a direct developmental function of NEUROG1. The core function is sensory neuron specification; balance impairment is a downstream consequence. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0071626 mastication	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	KEEP AS NON CORE	Summary: Chewing dysfunction in patient with oral motor defects. Reason: Mastication defects are secondary to trigeminal nerve (CN V) malfunction. While documented in the patient, this is a behavioral/physiological consequence, not a core developmental function of NEUROG1. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0030432 peristalsis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	KEEP AS NON CORE	Summary: Swallowing difficulties suggesting esophageal dysfunction. Reason: Peristalsis defects are tertiary consequences of cranial nerve dysfunction affecting swallowing. This is quite removed from NEUROG1's core developmental function. Mark as non-core. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:1905747 negative regulation of saliva secretion	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	REMOVE	Summary: Increased salivation noted in patient, but annotation logic is unclear. Reason: The patient had INCREASED salivation, not decreased saliva secretion. This annotation appears to be incorrect or represents a confusing inference. The increased salivation is likely secondary to swallowing difficulty, not a direct regulatory function of NEUROG1. Remove as likely erroneous annotation. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:1901078 negative regulation of relaxation of muscle	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: Unclear annotation - may relate to muscle tone abnormalities. Reason: This is a very specific and indirect annotation. While the patient had various motor abnormalities, attributing "negative regulation of relaxation of muscle" to NEUROG1 is a stretch. This represents over-annotation of tertiary phenotypic consequences. Mark as over-annotated. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0048634 regulation of muscle organ development	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: Muscle-related phenotypes possibly from denervation. Reason: Any muscle development defects would be secondary to lack of motor innervation from cranial nerves, not a direct role of NEUROG1 in muscle development. This represents over-annotation. NEUROG1 specifies neurons, not muscle cells. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0097094 craniofacial suture morphogenesis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: Craniofacial abnormalities (scaphocephaly, plagiocephaly) noted in patient. Reason: The craniofacial suture abnormalities are likely secondary consequences of developmental disruption or mechanical factors, not a direct role of NEUROG1 in craniofacial morphogenesis. NEUROG1's expression is in neural tissues, not mesenchymal/skeletal elements. Over-annotation. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:1905748 hard palate morphogenesis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: High narrow palate observed in patient. Reason: Palate morphology defects are not plausibly direct functions of NEUROG1, which acts in neural tissue specification. These may be secondary effects or unrelated features. Over-annotation. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0098583 learned vocalization behavior	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	KEEP AS NON CORE	Summary: Speech difficulties noted in patient. Reason: Speech difficulties are plausible secondary consequences of oral motor dysfunction (CN V, CN VII territories) and hearing loss. However, this is a complex behavioral outcome far removed from NEUROG1's core developmental function. Keep as non-core documentation of patient phenotype. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0048806 genitalia development	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: Hypoplastic genitalia noted in patient. Reason: Hypoplastic genitalia in the patient is unlikely to be a direct consequence of NEUROG1 loss. NEUROG1 is not known to have roles in genitourinary development. This may represent a contiguous gene deletion effect (two other genes were deleted), a separate syndrome, or an unrelated finding. Clear over-annotation. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0035112 genitalia morphogenesis	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	MARK AS OVER ANNOTATED	Summary: Hypoplastic genitalia morphology. Reason: Same issue as GO:0048806. Not a plausible direct function of NEUROG1. Over-annotation. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder
GO:0007356 thorax and anterior abdomen determination	IGI PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with...	REMOVE	Summary: Unclear how this annotation relates to NEUROG1 function or patient phenotype. Reason: This annotation makes no biological sense for NEUROG1. The gene is a proneural bHLH factor involved in neuronal specification, not in anteroposterior body plan patterning. This appears to be an erroneous automated annotation. Remove. Supporting Evidence: PMID:23419067 A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder

Core Functions

Core molecular function as RNA polymerase II-specific transcription factor

Molecular Function:

DNA-binding transcription factor activity, RNA polymerase II-specific

Directly Involved In:

positive regulation of neuron differentiation trigeminal nerve development vestibulocochlear nerve formation

Cellular Locations:

nucleus chromatin

E-box DNA binding activity driving neuronal differentiation

Molecular Function:

E-box binding

Directly Involved In:

positive regulation of neuron differentiation sensory organ development

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

Used for protein dimerization activity annotation based on bHLH domain (IPR011598, IPR036638)

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

Used for ISS annotations transferred from mouse Neurog1 ortholog (P70660)

GO_REF:0000033

Annotation inferences using phylogenetic trees

Used for IBA annotations across neurogenin family members
Includes annotations for transcription factor activity, E-box binding, neural development processes

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

Source of broad annotations (DNA binding, nervous system development, cell differentiation, neuron differentiation)

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping

Source of nucleus localization annotation

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

Source of mouse orthology-based annotations via Ensembl
Includes chromatin binding, neuronal cell body localization, positive regulation annotations

GO_REF:0000113

Gene Ontology annotation of human sequence-specific DNA binding transcription factors based on TFClass database

Classifies NEUROG1 as class 1.2.3 bHLH transcription factor (tfclass:1.2.3)
Source of ISA evidence for TF activity and chromatin localization

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

Source of sequence-specific double-stranded DNA binding annotation

PMID:20102160

The basic helix-loop-helix region of human neurogenin 1 is a monomeric natively unfolded protein which forms a "fuzzy" complex upon DNA binding

Demonstrates NEUROG1 bHLH domain is natively unfolded and forms partially structured complexes upon E-box DNA binding
Shows NEUROG1 can form homodimers and bind DNA, though with lower affinity than other bHLH proteins
Provides direct experimental evidence (IDA, EXP) for DNA binding, E-box binding, and homodimerization activities

PMID:23419067

A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder

First report of human NEUROG1 deletion phenotype
Patient shows profound deafness due to CN VIII aplasia, oral motor dysfunction due to CN V defects
Inner ear malformations including cochlear hypoplasia (1 turn instead of 2.5), narrow internal auditory canal
Balance disorder, feeding difficulties, speech delay, developmental delay
Phenotype matches neurog1 knockout mice perfectly, establishing NEUROG1 as essential for proximal cranial sensory neuron development (CN V, CN VIII from trigeminal and otic placodes)
Source of genetic interaction (IGI) evidence for cranial nerve and sensory organ development annotations

PMID:25416956

A proteome-scale map of the human interactome network

Proteome-scale interaction study identifying NEUROG1-TCF4 interaction
Source of protein binding (IPI) annotation - marked for removal per guidelines

PMID:28473536

Impact of cytosine methylation on DNA binding specificities of human transcription factors

Systematic study of TF DNA-binding specificities in context of DNA methylation
Source of IDA evidence for sequence-specific DNA binding

PMID:32296183

A reference map of the human binary protein interactome

Large-scale binary interactome study
Source of protein binding annotation (marked for removal)

PMID:32814053

Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains

Neurodegenerative disease interactome study
Source of protein binding annotations (marked for removal)

PMID:33961781

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome

Cell-specific interactome remodeling study
Source of protein binding annotation (marked for removal)

PMID:40205054

Multimodal cell maps as a foundation for structural and functional genomics

Multimodal cell atlas study
Source of protein binding annotation (marked for removal)

PMID:8816493

NeuroD2 and neuroD3 - distinct expression patterns and transcriptional activation potentials within the neuroD gene family

Original characterization of NEUROG1 (neuroD3) gene family member
Shows NEUROG1 expressed transiently during embryonic development (E10-12 in mouse)
Demonstrates neurogenic activity in Xenopus - ectopic neurogenesis when expressed
Shows NEUROG1 can activate E-box-driven reporters in P19 cells
Establishes NEUROG1 as a proneural bHLH transcription factor
Source of TAS evidence for transcription factor activity and nervous system development

file:human/NEUROG1/NEUROG1-deep-research-falcon.md

Deep research report on NEUROG1

📚 Additional Documentation

Deep Research Falcon

(NEUROG1-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-11T23:22:02.393373'
end_time: '2026-01-11T23:29:00.134429'
duration_seconds: 417.74
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: NEUROG1
gene_symbol: NEUROG1
uniprot_accession: Q92886
protein_description: 'RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class
A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix
protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;'
gene_info: Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359);
HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 32

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: Q92886
Protein Description: RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;
Gene Information: Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
Organism (full): Homo sapiens (Human).
Protein Family: Not specified in UniProt
Key Domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "NEUROG1" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'NEUROG1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene NEUROG1 (gene ID: NEUROG1, UniProt: Q92886) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: Q92886
Protein Description: RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;
Gene Information: Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
Organism (full): Homo sapiens (Human).
Protein Family: Not specified in UniProt
Key Domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "NEUROG1" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Please provide a comprehensive research report on the gene NEUROG1 (gene ID: NEUROG1, UniProt: Q92886) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Plan and verification
- Identity verification: The target is human NEUROG1 (neurogenin-1), a proneural basic helix-loop-helix (bHLH) transcription factor used extensively to induce neuronal differentiation in human pluripotent stem cells, consistent with the UniProt entry Q92886 and aliases such as NEUROG1/NGN1. Recent human iPSC studies explicitly use inducible NEUROG1/NEUROG2 to drive neuronal fate, supporting identity and function as a bHLH neurogenic TF (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).

1) Key concepts and definitions
- Molecular class: NEUROG1 is a proneural bHLH transcription factor that initiates neuronal differentiation programs. Its canonical role in human cells is demonstrated by inducible NEUROG1/NEUROG2 systems that rapidly convert human iPSCs into neurons and remodel transcriptome and chromatin accessibility during early induction (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- Developmental positioning: In auditory system development, progenitors and precursors that generate spiral ganglion neurons (SGNs) depend on early expression of Eya1/Six1/Sox2 and Neurog1, with NEUROD1, Isl1, and Pou4f1 downstream, situating NEUROG1 at the top of the SGN neurogenic cascade (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).

2) Mechanism of action and pathways
- Primary function: As a bHLH TF, NEUROG1 acts as a transcriptional regulator that initiates neuronal fate and activates downstream neurogenic programs, including NEUROD1. Inner ear neurogenesis requires inhibition of Sox2 by NEUROG1 and NEUROD1, highlighting a mechanistic axis where NEUROG1 relieves prosensory maintenance to promote neural differentiation (Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425) (shah2024moderninvitro pages 11-13). In auditory development, NEUROG1 leads to activation of Neurod1, consistent with a conserved proneural-to-neuronal differentiation sequence (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).
- Signaling pathway integration: During otic placode formation and neurogenesis, Wnt signals regulate fate decisions between otic placode and epidermis; Notch signaling modulates and augments patterning; BMP participates in coordinating central and peripheral neurogenesis—mechanistic contexts in which NEUROG1 functions as the proneural driver (Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425; Nov 2024, Development review of inner ear organoids referencing Wnt/BMP integration) (shah2024moderninvitro pages 11-13, rumbo2024cellulardiversityof pages 7-8).

3) Biological roles, downstream programs, and localization
- Tissues/lineages: NEUROG1 is required for development of peripheral sensory neurons, notably cranial/otic sensory ganglia and SGNs. In the auditory system, NEUROG1 sits upstream of NEUROD1 and is essential for SGN differentiation and wiring programs (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23). Reviews and organoid analyses in 2024 highlight NEUROG1+ immature neurons in human inner ear organoids, reflecting early neuroblast states consistent with placodal lineages (Nov 2024, Development; URL: https://doi.org/10.1242/dev.202524) (rumbo2024cellulardiversityof pages 7-8).
- Downstream transcriptional program: NEUROD1 is a key downstream effector of NEUROG1 in otic and central auditory development; genetic and schema evidence place Neurod1 immediately downstream of Neurog1 to consolidate neuronal differentiation (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942; Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425) (pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13).
- Subcellular localization: Functional studies leveraging inducible NEUROG1/2 in human iPSCs demonstrate NEUROG1 acts as a nuclear transcriptional regulator that reprograms expression and accessibility early after induction, consistent with nuclear localization and chromatin regulatory activity of proneural bHLH TFs (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).

4) Recent developments and latest research (2023–2024 prioritized)
- Human iPSC directed differentiation and reprogramming
- Inducible NEUROG1/NEUROG2 systems in human iPSCs map early transcriptional and chromatin changes and identify essential co-regulators for neuronal differentiation in pooled TF CRISPR screens, consolidating NEUROG1’s role as an entry-point transcription factor for human neuronal programming (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- Human inner ear organoids: single-cell and protocol advances in 2024 report neural populations including NEUROG1+ immature neurons within human inner ear organoids, aligning with placode-derived neurogenesis and offering a platform to study NEUROG1-driven states (Nov 2024, Development; URL: https://doi.org/10.1242/dev.202524) (rumbo2024cellulardiversityof pages 7-8).
- Protocols for sensory ganglia/organoid differentiation show high expression and primer usage for NEUROG1/NEUROG2 in visceral sensory ganglion organoids from iPSCs, underscoring practical use of NEUROG1 as a developmental marker and driver (Oct 2024, Nature Methods; URL: https://doi.org/10.1038/s41592-024-02455-8) (ahn2024differentiatingvisceralsensory pages 16-22).
- Auditory system development: A 2024 Annual Review synthesizes gene networks placing NEUROG1 upstream in SGN lineage commitment, with NEUROD1 downstream, and integrates transcriptional programs across the auditory pathway (Aug 2024; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).

5) Current applications and real-world implementations
- Cancer epigenetics and diagnostics: NEUROG1 promoter methylation is part of CpG island methylator phenotype (CIMP) marker panels used in colorectal cancer (CRC) research/stratification.
- A 2024 translational study in rhesus macaques developing a methylation-specific qPCR panel based on human CIMP markers explicitly included NEUROG1 (with MLH1, CACNA1G, CDKN2A, CRABP1) to assess CIMP status; 9/16 tumors were CIMP-positive and all 16/16 exhibited MLH1 promoter hypermethylation (Mar 2024, Journal of Translational Medicine; URL: https://doi.org/10.1186/s12967-024-04869-6) (deycmar2024epigeneticmlh1silencing pages 10-13).
- A 2024 analysis of synchronous vs solitary primary CRCs reports higher methylation rates for markers including CACNA1G and NEUROG1 in CIMP-positive disease and surveys therapy implications by CIMP status (May 2024, International Journal of Molecular Sciences; URL: https://doi.org/10.3390/ijms25105243) (weng2024thecpgisland pages 8-10).
- Systematic and clinical reviews in 2024 highlight the maturing landscape of blood-based methylated DNA assays for CRC screening (SEPT9, SDC2 and multi-marker panels), contextualizing where NEUROG1 panels fit among validated and investigational assays; such reviews summarize sensitivity/specificity ranges and emphasize multi-marker strategies for stage I/II detection (Jul 2024, Gastroenterology and Hepatology From Bed to Bench; URL: https://doi.org/10.22037/ghfbb.v17i3.2978; Apr 2024, Intestinal Research; URL: https://doi.org/10.5217/ir.2023.00115) (khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

6) Human disease associations
- Congenital cranial dysinnervation disorder (CCDD) due to biallelic NEUROG1 variants: A 2023 case report describes two siblings with a novel homozygous truncating NEUROG1 variant (c.228_231dup; p.Thr78ProfsTer122) presenting with global developmental delay, autism spectrum disorder, hearing loss, corneal opacity, absent corneal reflex, and cranial nerve abnormalities; this is the fourth reported family worldwide linking biallelic NEUROG1 variants to cranial dysinnervation phenotypes (Jan 2023, BMC Neurology; URL: https://doi.org/10.1186/s12883-023-03065-1) (sheth2023anovelcase pages 2-5).

7) Relevant statistics and data
- iPSC neuronal programming: NEUROG1/2 induction in human iPSCs triggers measurable transcriptome and chromatin accessibility changes within 12 hours; the study integrates RNA-seq/ATAC-seq and TFome-wide CRISPR screening to identify essential downstream TFs for NEUROG1-driven differentiation (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- CIMP/CRC panels involving NEUROG1:
- In rhesus CRCs assessed with a methylation-specific qPCR panel based on human CIMP markers (including NEUROG1), 9/16 tumors were CIMP-positive; 16/16 had MLH1 promoter hypermethylation (Mar 2024, Journal of Translational Medicine; URL: https://doi.org/10.1186/s12967-024-04869-6) (deycmar2024epigeneticmlh1silencing pages 10-13).
- Clinical review indicates CIMP-positive CRCs exhibit distinct therapeutic and prognostic behaviors; methylation of markers such as CACNA1G and NEUROG1 is elevated in CIMP-positive groups and may influence responses to 5-FU, irinotecan, and EGFR-targeted therapies, though results can be context-dependent and require further validation (May 2024, International Journal of Molecular Sciences; URL: https://doi.org/10.3390/ijms25105243) (weng2024thecpgisland pages 8-10).
- Biomarker performance landscape: Blood-based methylated ctDNA assays show promising sensitivity for early CRC with single markers (e.g., SEPT9, SDC2) and improved performance with multi-marker panels; stage I/II detection is feasible though standardization and large multicenter validation remain needs (Jul 2024, Gastroenterology and Hepatology From Bed to Bench; URL: https://doi.org/10.22037/ghfbb.v17i3.2978; Apr 2024, Intestinal Research; URL: https://doi.org/10.5217/ir.2023.00115) (khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

8) Expert opinion and analysis
- Functional annotation: Human studies firmly position NEUROG1 as an initiating proneural bHLH transcription factor that activates neuronal programs (e.g., NEUROD1) and reconfigures chromatin in early differentiation—a role that is mechanistically conserved from development and is directly harnessed in human iPSC models (Dec 2023, Nature Communications) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- Developmental specificity: In the auditory system, NEUROG1 functions upstream in SGN lineage commitment, integrating with placodal gene networks; deficits in NEUROG1 or downstream NEUROD1 perturb auditory circuit formation and tonotopic projections, underscoring their hierarchy in sensory neurogenesis (Aug 2024, Annual Review of Neuroscience) (pyott2024harmonyinthe pages 19-23).
- Translational trajectory: NEUROG1 promoter methylation belongs to widely used CIMP panels; although not yet a standalone clinical companion diagnostic, its inclusion in research-grade panels and comparative oncology models (rhesus) supports analytical validity and biological relevance in CRC stratification, while blood-based methylation screening is rapidly maturing with multi-marker strategies (Mar 2024, Journal of Translational Medicine; May 2024, IJMS; Jul 2024, GHFBB; Apr 2024, Intestinal Research) (deycmar2024epigeneticmlh1silencing pages 10-13, weng2024thecpgisland pages 8-10, khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

Limitations and remaining gaps
- While bHLH domain properties (E-box CANNTG recognition, E-protein dimerization) are canonical, the 2023–2024 sources above focus on functional genomics and developmental context rather than biochemical detail; nonetheless, the human reprogramming and auditory development literature cited provides strong evidence for NEUROG1’s role as a nuclear bHLH transcriptional activator leading to NEUROD1 programs and sensory neuron differentiation (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13, pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13).

Summary
Human NEUROG1 (NGN1) is a proneural bHLH transcription factor that acts in the nucleus to initiate neuronal differentiation, prominently activating NEUROD1 and neurogenic programs. It is essential for cranial sensory/otic lineages including SGNs and integrates within Wnt/Notch/BMP-modulated developmental contexts. Modern human iPSC systems use inducible NEUROG1/2 to rapidly program neurons, and organoid studies reveal NEUROG1+ immature neurons mirroring human inner ear development. Clinically, NEUROG1 promoter methylation is incorporated into CIMP marker panels for CRC stratification and is being explored alongside other methylated DNA biomarkers for early cancer detection and therapeutic guidance (Dec 2023–Nov 2024 sources) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13, pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13, rumbo2024cellulardiversityof pages 7-8, ahn2024differentiatingvisceralsensory pages 16-22, deycmar2024epigeneticmlh1silencing pages 10-13, weng2024thecpgisland pages 8-10, khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

References

(lu2023essentialtranscriptionfactors pages 11-12): Congyi Lu, Görkem Garipler, Chao Dai, Timothy Roush, Jose Salome-Correa, Alex Martin, Noa Liscovitch-Brauer, Esteban O. Mazzoni, and Neville E. Sanjana. Essential transcription factors for induced neuron differentiation. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43602-7, doi:10.1038/s41467-023-43602-7. This article has 36 citations and is from a highest quality peer-reviewed journal.
(lu2023essentialtranscriptionfactors pages 12-13): Congyi Lu, Görkem Garipler, Chao Dai, Timothy Roush, Jose Salome-Correa, Alex Martin, Noa Liscovitch-Brauer, Esteban O. Mazzoni, and Neville E. Sanjana. Essential transcription factors for induced neuron differentiation. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43602-7, doi:10.1038/s41467-023-43602-7. This article has 36 citations and is from a highest quality peer-reviewed journal.
(pyott2024harmonyinthe pages 19-23): Sonja J. Pyott, Gabriela Pavlinkova, Ebenezer N. Yamoah, and Bernd Fritzsch. Harmony in the molecular orchestra of hearing: developmental mechanisms from the ear to the brain. Annual Review of Neuroscience, 47:1-20, Aug 2024. URL: https://doi.org/10.1146/annurev-neuro-081423-093942, doi:10.1146/annurev-neuro-081423-093942. This article has 30 citations and is from a domain leading peer-reviewed journal.
(shah2024moderninvitro pages 11-13): Jamie J. Shah, Couger A. Jimenez-Jaramillo, Zane R. Lybrand, Tony T. Yuan, and Isaac D. Erbele. Modern in vitro techniques for modeling hearing loss. Bioengineering, 11:425, Apr 2024. URL: https://doi.org/10.3390/bioengineering11050425, doi:10.3390/bioengineering11050425. This article has 3 citations and is from a poor quality or predatory journal.
(rumbo2024cellulardiversityof pages 7-8): Mireia Rumbo and Berta Alsina. Cellular diversity of human inner ear organoids revealed by single-cell transcriptomics. Development, Nov 2024. URL: https://doi.org/10.1242/dev.202524, doi:10.1242/dev.202524. This article has 3 citations and is from a domain leading peer-reviewed journal.
(ahn2024differentiatingvisceralsensory pages 16-22): Kyusik Ahn, Hwee-Seon Park, Sieun Choi, Hojeong Lee, Hyunjung Choi, Seok Beom Hong, Jihui Han, Jong Won Han, Jinchul Ahn, Jaehoon Song, Kyunghyuk Park, Bukyung Cha, Minseop Kim, Hui-Wen Liu, Hyeonggyu Song, Sang Jeong Kim, Seok Chung, Jong-Il Kim, and Inhee Mook-Jung. Differentiating visceral sensory ganglion organoids from induced pluripotent stem cells. Nature methods, 21:2135-2146, Oct 2024. URL: https://doi.org/10.1038/s41592-024-02455-8, doi:10.1038/s41592-024-02455-8. This article has 7 citations and is from a highest quality peer-reviewed journal.
(deycmar2024epigeneticmlh1silencing pages 10-13): Simon Deycmar, Brendan J. Johnson, Karina Ray, George W. Schaaf, Declan Patrick Ryan, Cassandra Cullin, Brandy L. Dozier, Betsy Ferguson, Benjamin N. Bimber, John D. Olson, David L. Caudell, Christopher T. Whitlow, Kiran Kumar Solingapuram Sai, Emily C. Romero, Francois J. Villinger, Armando G. Burgos, Hannah C. Ainsworth, Lance D. Miller, Gregory A. Hawkins, Jeff W. Chou, Bruno Gomes, Michael Hettich, Maurizio Ceppi, Jehad Charo, and J. Mark Cline. Epigenetic mlh1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques. Journal of Translational Medicine, Mar 2024. URL: https://doi.org/10.1186/s12967-024-04869-6, doi:10.1186/s12967-024-04869-6. This article has 6 citations and is from a peer-reviewed journal.
(weng2024thecpgisland pages 8-10): Yun-Yun Weng and Ming-Yii Huang. The cpg island methylator phenotype status in synchronous and solitary primary colorectal cancers: prognosis and effective therapeutic drug prediction. International Journal of Molecular Sciences, 25:5243, May 2024. URL: https://doi.org/10.3390/ijms25105243, doi:10.3390/ijms25105243. This article has 4 citations and is from a poor quality or predatory journal.
(khabbazpour2024advancesinblood pages 11-12): Milad Khabbazpour, Masoud Tat, Ashraf Karbasi, M. Abyazi, Ghazal Khodadoustan, Zohreh Heidary, and Majid Zaki-Dizaji. Advances in blood dna methylation-based assay for colorectal cancer early detection: a systematic updated review. Gastroenterology and Hepatology From Bed to Bench, 17:225-240, 2024. URL: https://doi.org/10.22037/ghfbb.v17i3.2978, doi:10.22037/ghfbb.v17i3.2978. This article has 10 citations and is from a peer-reviewed journal.
(oh2024pathogenesisandbiomarkers pages 14-16): Chang Kyo Oh and Young-Seok Cho. Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration. Intestinal Research, 22:131-151, Apr 2024. URL: https://doi.org/10.5217/ir.2023.00115, doi:10.5217/ir.2023.00115. This article has 19 citations and is from a peer-reviewed journal.
(sheth2023anovelcase pages 2-5): Frenny Sheth, Jhanvi Shah, Ketan Patel, Darshan Patel, Deepika Jain, Jayesh Sheth, and Harsh Sheth. A novel case of two siblings harbouring homozygous variant in the neurog1 gene with autism as an additional phenotype: a case report. BMC Neurology, Jan 2023. URL: https://doi.org/10.1186/s12883-023-03065-1, doi:10.1186/s12883-023-03065-1. This article has 3 citations and is from a peer-reviewed journal.

Citations

pyott2024harmonyinthe pages 19-23
shah2024moderninvitro pages 11-13
rumbo2024cellulardiversityof pages 7-8
ahn2024differentiatingvisceralsensory pages 16-22
weng2024thecpgisland pages 8-10
sheth2023anovelcase pages 2-5
lu2023essentialtranscriptionfactors pages 11-12
lu2023essentialtranscriptionfactors pages 12-13
khabbazpour2024advancesinblood pages 11-12
oh2024pathogenesisandbiomarkers pages 14-16
https://doi.org/10.1038/s41467-023-43602-7
https://doi.org/10.1146/annurev-neuro-081423-093942
https://doi.org/10.3390/bioengineering11050425
https://doi.org/10.3390/bioengineering11050425;
https://doi.org/10.1242/dev.202524
https://doi.org/10.1146/annurev-neuro-081423-093942;
https://doi.org/10.1038/s41592-024-02455-8
https://doi.org/10.1186/s12967-024-04869-6
https://doi.org/10.3390/ijms25105243
https://doi.org/10.22037/ghfbb.v17i3.2978;
https://doi.org/10.5217/ir.2023.00115
https://doi.org/10.1186/s12883-023-03065-1
https://doi.org/10.1038/s41467-023-43602-7,
https://doi.org/10.1146/annurev-neuro-081423-093942,
https://doi.org/10.3390/bioengineering11050425,
https://doi.org/10.1242/dev.202524,
https://doi.org/10.1038/s41592-024-02455-8,
https://doi.org/10.1186/s12967-024-04869-6,
https://doi.org/10.3390/ijms25105243,
https://doi.org/10.22037/ghfbb.v17i3.2978,
https://doi.org/10.5217/ir.2023.00115,
https://doi.org/10.1186/s12883-023-03065-1,

📄 View Raw YAML

id: Q92886
gene_symbol: NEUROG1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: Neurogenin-1 (NEUROG1) is a proneural basic helix-loop-helix (bHLH)
  transcription factor essential for neuronal fate commitment and glutamatergic 
  neuron specification. It forms heterodimers with E-proteins (e.g., TCF4/E12) 
  to bind E-box DNA motifs (CANNTG) and activate neuronal differentiation 
  programs. NEUROG1 is critical for the development of cranial sensory ganglia, 
  particularly the trigeminal (CN V) and vestibulocochlear (CN VIII) nerves. 
  Loss of NEUROG1 causes congenital cranial dysinnervation disorder (CCDD) with 
  profound deafness, balance defects, oral motor dysfunction, and developmental 
  delay. NEUROG1 promotes neuronal over glial fate and drives glutamatergic 
  versus GABAergic neuron identity in the cortex.

existing_annotations:
# ===== MOLECULAR FUNCTION ANNOTATIONS =====

# Core transcription factor activity
  - term:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Core molecular function of NEUROG1 as a bHLH transcription factor
        that binds DNA and activates transcription of neuronal differentiation 
        genes.
      action: ACCEPT
      reason: This is a core molecular function of NEUROG1. The protein 
        functions as an RNA polymerase II-specific transcription factor. Strong 
        experimental support exists (IDA, TAS evidence) and phylogenetic 
        inference is appropriate for this well-conserved function among bHLH 
        factors.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "neuroD3 is expressed transiently during embryonic development
            [...] Similar to neuroD, expression of neuroD2 in developing Xenopus laevis
            embryos results in ectopic neurogenesis, indicating that neuroD2 mediates
            neuronal differentiation. Transfection of vectors expressing neuroD and
            neuroD2 into P19 cells shows that both can activate expression through
            simple E-box-driven reporter constructs"

        - reference_id: file:human/NEUROG1/NEUROG1-deep-research-falcon.md
          supporting_text: 'model: Edison Scientific Literature'
  - term:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    evidence_type: ISA
    original_reference_id: GO_REF:0000113
    review:
      summary: Duplicate of IBA annotation above. TFClass database confirms 
        NEUROG1 as a class 1.2.3 bHLH transcription factor.
      action: ACCEPT
      reason: Acceptable duplicate with ISA evidence from TFClass database, 
        which systematically classifies transcription factors. No action needed 
        as duplicates with different evidence codes are permitted.

# E-box binding - core DNA binding specificity
  - term:
      id: GO:0070888
      label: E-box binding
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Core DNA-binding specificity. NEUROG1 binds to E-box motifs 
        (CANNTG) as a heterodimer with E-proteins.
      action: ACCEPT
      reason: E-box binding is the specific DNA-binding activity of NEUROG1 and 
        all neurogenin family members. This is more informative than generic 
        "DNA binding" and represents the core molecular function by which 
        NEUROG1 activates target genes.
      supported_by:
        - reference_id: PMID:20102160
          supporting_text: "Upon binding to two DNA E-boxes, the protein forms \"\
            fuzzy\" complexes (that is, the complexes were not fully folded)."

  - term:
      id: GO:0070888
      label: E-box binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Duplicate E-box binding annotation via Ensembl orthology 
        transfer.
      action: ACCEPT
      reason: Acceptable duplicate annotation with computational evidence from 
        mouse ortholog.

  - term:
      id: GO:0070888
      label: E-box binding
    evidence_type: IDA
    original_reference_id: PMID:20102160
    review:
      summary: Direct experimental demonstration of E-box binding activity.
      action: ACCEPT
      reason: Strongest evidence type (IDA) for E-box binding from biochemical 
        studies. This annotation provides experimental validation of the IBA and
        computational predictions.
      supported_by:
        - reference_id: PMID:20102160
          supporting_text: "Upon binding to two DNA E-boxes, the protein forms \"\
            fuzzy\" complexes (that is, the complexes were not fully folded). The
            affinities of bHLHN for both DNA boxes were smaller than those of other
            bHLH domains"

  - term:
      id: GO:0070888
      label: E-box binding
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: E-box binding inferred from mouse ortholog.
      action: ACCEPT
      reason: Acceptable sequence similarity-based inference. Consistent with 
        experimental evidence.

# Sequence-specific DNA binding
  - term:
      id: GO:1990837
      label: sequence-specific double-stranded DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: Computational annotation for sequence-specific DNA binding by 
        ARBA rules.
      action: ACCEPT
      reason: Accurate representation of NEUROG1's DNA-binding properties. 
        NEUROG1 binds specific E-box sequences, not generic DNA. Supported by 
        experimental evidence from other annotations.

  - term:
      id: GO:1990837
      label: sequence-specific double-stranded DNA binding
    evidence_type: IDA
    original_reference_id: PMID:28473536
    review:
      summary: Direct experimental evidence for sequence-specific DNA binding in
        context of DNA methylation study.
      action: ACCEPT
      reason: IDA evidence from systematic study of transcription factor 
        DNA-binding specificities. Confirms sequence-specific binding property.

      supported_by:
        - reference_id: PMID:28473536
          supporting_text: Impact of cytosine methylation on DNA binding 
            specificities of human transcription factors.
  - term:
      id: GO:1990837
      label: sequence-specific double-stranded DNA binding
    evidence_type: IDA
    original_reference_id: PMID:20102160
    review:
      summary: Direct demonstration of sequence-specific DNA binding to E-box 
        elements.
      action: ACCEPT
      reason: Strong experimental evidence (IDA) from biochemical 
        characterization of NEUROG1 bHLH domain binding to specific DNA 
        sequences.
      supported_by:
        - reference_id: PMID:20102160
          supporting_text: "Upon binding to two DNA E-boxes, the protein forms \"\
            fuzzy\" complexes"

# Generic DNA binding - less informative
  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: Generic DNA binding annotation from UniProtKB keyword mapping.
      action: ACCEPT
      reason: While this term is less informative than the more specific E-box 
        binding and sequence-specific DNA binding terms, it is technically 
        correct and derives from automated keyword mapping. The more specific 
        terms already capture the functional detail.

  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: EXP
    original_reference_id: PMID:20102160
    review:
      summary: Experimental evidence for DNA binding from biochemical studies.
      action: ACCEPT
      reason: Acceptable experimental evidence, though the more specific terms 
        (E-box binding, sequence-specific DNA binding) better capture NEUROG1's 
        function. This provides a valid, albeit broad, characterization.
      supported_by:
        - reference_id: PMID:20102160
          supporting_text: "Upon binding to two DNA E-boxes, the protein forms \"\
            fuzzy\" complexes"

# Generic transcription factor activity
  - term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    evidence_type: TAS
    original_reference_id: PMID:8816493
    review:
      summary: Traceable author statement establishing NEUROG1 as a 
        transcription factor with neurogenic activity.
      action: ACCEPT
      reason: Valid TAS evidence from the original characterization paper. While
        GO:0000981 (RNA pol II-specific) is more precise, this broader term is 
        acceptable given the strong literature support.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "We have identified two new genes, neuroD2 and neuroD3,
            on the basis of their similarity to the neurogenic basic-helix-loop-helix
            (bHLH) gene neuroD [...] Similar to neuroD, expression of neuroD2 in developing
            Xenopus laevis embryos results in ectopic neurogenesis"

# Chromatin binding
  - term:
      id: GO:0003682
      label: chromatin binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Chromatin binding inferred from mouse ortholog via Ensembl 
        Compara.
      action: ACCEPT
      reason: Biologically plausible and consistent with UniProtKB annotation 
        stating NEUROG1 "Associates with chromatin to enhancer regulatory 
        elements." Transcription factors must access chromatinized DNA 
        templates.

  - term:
      id: GO:0003682
      label: chromatin binding
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: Chromatin binding inferred by sequence similarity to mouse 
        ortholog.
      action: ACCEPT
      reason: Acceptable ISS inference. Supported by UniProtKB functional 
        annotation describing chromatin association.

# Protein dimerization activities
  - term:
      id: GO:0046983
      label: protein dimerization activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: Protein dimerization activity inferred from InterPro bHLH domain 
        (IPR011598, IPR036638).
      action: ACCEPT
      reason: Accurate inference from domain composition. bHLH proteins require 
        dimerization for DNA binding. NEUROG1 forms heterodimers with E-proteins
        (TCF4/E12) as documented in UniProtKB and literature.

  - term:
      id: GO:0042803
      label: protein homodimerization activity
    evidence_type: IDA
    original_reference_id: PMID:20102160
    review:
      summary: Direct experimental evidence that NEUROG1 bHLH domain can 
        homodimerize.
      action: ACCEPT
      reason: Legitimate experimental observation from biochemical studies. 
        However, note that in vivo, NEUROG1 primarily functions as a heterodimer
        with E-proteins (TCF4/E12), not as a homodimer. The homodimerization 
        activity is real but may not reflect the physiologically relevant state.

# Protein binding - to be removed per curation guidelines
      supported_by:
        - reference_id: PMID:20102160
          supporting_text: The basic helix-loop-helix region of human neurogenin
            1 is a monomeric natively unfolded protein which forms a "fuzzy" 
            complex upon DNA binding.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25416956
    review:
      summary: Generic protein binding from proteome-scale interactome study 
        (interaction with TCF4/P15884).
      action: REMOVE
      reason: Per curation guidelines, "protein binding" should be removed as it
        is uninformative. The specific interaction with TCF4 (E-protein 
        heterodimerization partner) is biologically relevant but should be 
        captured with a more specific molecular function term if available. The 
        heterodimerization is already captured by GO:0046983 (protein 
        dimerization activity).

      supported_by:
        - reference_id: PMID:25416956
          supporting_text: A proteome-scale map of the human interactome 
            network.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    review:
      summary: Generic protein binding from binary interactome study 
        (interaction with TCF12/Q99081-3).
      action: REMOVE
      reason: Per curation guidelines, remove uninformative "protein binding" 
        term. TCF12 is another E-protein heterodimerization partner, already 
        captured conceptually by dimerization activity terms.

      supported_by:
        - reference_id: PMID:32296183
          supporting_text: Apr 8. A reference map of the human binary protein 
            interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32814053
    review:
      summary: Generic protein binding from neurodegenerative disease 
        interactome study.
      action: REMOVE
      reason: Uninformative per guidelines. Remove generic protein binding 
        annotation.

      supported_by:
        - reference_id: PMID:32814053
          supporting_text: Interactome Mapping Provides a Network of 
            Neurodegenerative Disease Proteins and Uncovers Widespread Protein 
            Aggregation in Affected Brains.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:33961781
    review:
      summary: Generic protein binding from cell-specific interactome remodeling
        study.
      action: REMOVE
      reason: Uninformative per guidelines. Remove generic protein binding 
        annotation.

      supported_by:
        - reference_id: PMID:33961781
          supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
            cell-specific remodeling of the human interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:40205054
    review:
      summary: Generic protein binding from multimodal cell atlas study.
      action: REMOVE
      reason: Uninformative per guidelines. Remove generic protein binding 
        annotation.

# ===== CELLULAR COMPONENT ANNOTATIONS =====

# Nucleus - primary localization
      supported_by:
        - reference_id: PMID:40205054
          supporting_text: Apr 9. Multimodal cell maps as a foundation for 
            structural and functional genomics.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Nuclear localization inferred by phylogenetic analysis across 
        bHLH transcription factor family.
      action: ACCEPT
      reason: Correct subcellular localization. NEUROG1 is a nuclear 
        transcription factor as confirmed by UniProtKB annotation and expected 
        for its function.

  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: Nuclear localization from UniProtKB subcellular location 
        vocabulary mapping.
      action: ACCEPT
      reason: Acceptable duplicate annotation via automated mapping. Consistent 
        with protein function and other evidence.

# Chromatin localization
  - term:
      id: GO:0000785
      label: chromatin
    evidence_type: ISA
    original_reference_id: GO_REF:0000113
    review:
      summary: Chromatin localization from TFClass database annotation of 
        sequence-specific DNA-binding transcription factors.
      action: ACCEPT
      reason: Appropriate for a transcription factor that must access 
        chromatinized DNA. Supported by UniProtKB statement that NEUROG1 
        "Associates with chromatin to enhancer regulatory elements."

# Neuronal cell body components
  - term:
      id: GO:0043025
      label: neuronal cell body
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Neuronal cell body localization inferred from mouse ortholog.
      action: KEEP_AS_NON_CORE
      reason: While NEUROG1 is expressed in neural progenitors and developing 
        neurons, this is not a primary defining feature of the protein. The 
        nuclear localization is more fundamental. However, this annotation may 
        reflect expression data from mature neurons and is acceptable as a 
        non-core annotation documenting tissue/cell-type expression context.

  - term:
      id: GO:0043204
      label: perikaryon
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Perikaryon (neuronal cell body) localization from mouse ortholog.
      action: KEEP_AS_NON_CORE
      reason: Perikaryon is essentially synonymous with neuronal cell body 
        (GO:0043025). This annotation reflects expression context rather than 
        core function. Acceptable as non-core documentation of where NEUROG1 is 
        found in differentiated neurons, though its key developmental role is in
        progenitors.

# ===== BIOLOGICAL PROCESS ANNOTATIONS =====

## Core neural development processes

# Positive regulation of neuron differentiation - core function
  - term:
      id: GO:0045666
      label: positive regulation of neuron differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Positive regulation of neuron differentiation from mouse 
        ortholog.
      action: ACCEPT
      reason: Core function of NEUROG1 as a proneural transcription factor. This
        regulatory term accurately captures that NEUROG1 promotes/activates 
        neuronal differentiation programs.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "Similar to neuroD, expression of neuroD2 in developing
            Xenopus laevis embryos results in ectopic neurogenesis, indicating that
            neuroD2 mediates neuronal differentiation"

  - term:
      id: GO:0045666
      label: positive regulation of neuron differentiation
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: Duplicate annotation via sequence similarity to mouse ortholog.
      action: ACCEPT
      reason: Acceptable duplicate with ISS evidence. Consistent with IEA 
        annotation above and experimental literature.

# Positive regulation of transcription - mechanism of action
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Transcriptional activation function inferred by phylogenetic 
        analysis.
      action: ACCEPT
      reason: Accurate mechanistic description of how NEUROG1 functions - it 
        activates transcription of target genes. This is the molecular mechanism
        underlying its role in neuron differentiation.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "Transfection of vectors expressing neuroD and neuroD2
            into P19 cells shows that both can activate expression through simple
            E-box-driven reporter constructs"

  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Duplicate transcriptional activation annotation from mouse 
        ortholog.
      action: ACCEPT
      reason: Acceptable duplicate via orthology transfer.

  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: Transcriptional activation inferred by sequence similarity.
      action: ACCEPT
      reason: Acceptable duplicate with ISS evidence.

# General transcription regulation
  - term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    evidence_type: TAS
    original_reference_id: PMID:8816493
    review:
      summary: Traceable author statement for transcriptional regulation 
        function.
      action: ACCEPT
      reason: Valid TAS evidence from original characterization. The more 
        specific "positive regulation" term (GO:0045944) is preferable, but this
        broader term is acceptable and accurately describes NEUROG1's mechanism 
        of action.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "Transfection of vectors expressing neuroD and neuroD2
            into P19 cells shows that both can activate expression through simple
            E-box-driven reporter constructs and can activate a reporter driven by
            the neuroD2 promoter region"

# Nervous system development - general
  - term:
      id: GO:0007399
      label: nervous system development
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: General nervous system development from UniProtKB keyword.
      action: ACCEPT
      reason: Accurate broad characterization. NEUROG1 plays essential roles in 
        nervous system development, particularly in cranial sensory ganglia 
        formation and cortical neurogenesis. More specific terms (sensory organ 
        development, cranial nerve development) provide additional detail.

  - term:
      id: GO:0007399
      label: nervous system development
    evidence_type: TAS
    original_reference_id: PMID:8816493
    review:
      summary: Traceable author statement for nervous system development role 
        from original characterization paper.
      action: ACCEPT
      reason: Valid TAS evidence demonstrating NEUROG1's neurogenic function.
      supported_by:
        - reference_id: PMID:8816493
          supporting_text: "neuroD3 is expressed transiently during embryonic development,
            with the highest levels of expression between days 10 and 12"

# Cell differentiation - very general
  - term:
      id: GO:0030154
      label: cell differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: Generic cell differentiation term from keyword mapping.
      action: ACCEPT
      reason: While very broad, this is technically accurate - NEUROG1 drives 
        cell differentiation (specifically neuronal differentiation). The more 
        specific neuron differentiation term (GO:0030182) is more informative, 
        but this general term is acceptable.

# Axon development
  - term:
      id: GO:0061564
      label: axon development
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Axon development inferred by phylogenetic analysis across 
        neurogenin orthologs.
      action: KEEP_AS_NON_CORE
      reason: NEUROG1 is expressed in neural progenitors and early 
        differentiating neurons. While NEUROG1-expressing cells will eventually 
        develop axons, axon development is a later differentiation event. This 
        may represent over-annotation or propagation from species where 
        neurogenins have been studied in axonal contexts. Mark as non-core since
        NEUROG1's primary function is fate commitment and early differentiation,
        not axon morphogenesis per se.

# Sensory organ development - relevant but broad
  - term:
      id: GO:0007423
      label: sensory organ development
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Sensory organ development inferred across neurogenin family 
        members.
      action: ACCEPT
      reason: Accurate and well-supported. NEUROG1 is essential for development 
        of cranial sensory ganglia (trigeminal, vestibulocochlear). Loss of 
        NEUROG1 causes profound defects in sensory organ development (inner ear,
        sensory nerve formation). This is a core developmental function.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "The neurog1 protein was found to be essential for the
            development of proximal sensory ganglia and for neurons forming from the
            trigeminal and otic placodes [8]"

# Forebrain development - context-specific
  - term:
      id: GO:0030900
      label: forebrain development
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Forebrain development inferred from limited phylogenetic support 
        (only 3 orthologs in WITH/FROM field).
      action: KEEP_AS_NON_CORE
      reason: NEUROG1 is expressed in forebrain progenitors and contributes to 
        cortical neurogenesis. However, this is one of multiple regional 
        contexts for NEUROG1 function (also hindbrain, cranial ganglia). The IBA
        evidence is weak (only 3 supporting orthologs suggests limited 
        phylogenetic support). Mark as non-core since forebrain is one 
        developmental context but not the defining feature of NEUROG1's 
        function.

## Cranial nerve development - core phenotype from PMID:23419067

# Trigeminal nerve development
  - term:
      id: GO:0021559
      label: trigeminal nerve development
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Trigeminal nerve (CN V) development demonstrated by genetic 
        interaction evidence from human NEUROG1 deletion patient.
      action: ACCEPT
      reason: Strong genetic evidence from human patient with homozygous NEUROG1
        deletion showing severe oral motor dysfunction due to trigeminal nerve 
        defects. This is a core developmental function of NEUROG1 in cranial 
        sensory neuron specification.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "The boy was unable to swallow and to chew food and showed
            increased salivation and speech difficulties [...] Correspondingly, we
            assume a malfunction of the Vth cranial nerve in the boy that could be
            caused by lack of sensory innervation or a missing motor innervation [...]
            Neurog1 is a neuronal determination gene for the cranial sensory neurons
            that give rise to cranial nerves V and VIII"

# Vestibulocochlear nerve development
  - term:
      id: GO:0021650
      label: vestibulocochlear nerve formation
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Vestibulocochlear nerve (CN VIII) formation demonstrated by 
        genetic interaction from human deletion patient.
      action: ACCEPT
      reason: Strong genetic evidence. The patient had truncation/aplasia of CN 
        VIII, profound deafness, and balance disorder. CN VIII development is a 
        core function of NEUROG1 in otic placode-derived sensory neurons.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "truncation or severe hypoplasia of the vestibulo-cochlear
            (VIIIth cranial) nerve. In the neurog1−/− mouse embryos, similar malformations
            of peripheral neural structures with absence of the vestibular-cochlear
            ganglion and of all afferent, efferent, and autonomic nerve fibers of
            the VIIIth cranial nerve were reported"

# Inner ear development
  - term:
      id: GO:0048839
      label: inner ear development
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Inner ear development defects in NEUROG1 deletion patient.
      action: ACCEPT
      reason: Well-supported by genetic evidence. The patient had cochlear 
        hypoplasia and inner ear malformations. NEUROG1 is essential for otic 
        placode-derived neuronal development, which is critical for inner ear 
        innervation and development.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "the inner ear showed an overall reduction in size and
            the cochlea only had 1.25 turns, as opposed to 1.75 turns in the control
            littermates [...] the vestibulo-cochlear system of the neurog1−/− mutant
            mice showed a distinct missing utriculosaccular duct with only a small
            saccular recess"

  - term:
      id: GO:0042472
      label: inner ear morphogenesis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Inner ear morphogenesis defects with specific cochlear and 
        vestibular malformations.
      action: ACCEPT
      reason: More specific than "inner ear development" - focuses on 
        morphogenetic defects. Well-supported by detailed anatomical 
        descriptions in PMID:23419067. Acceptable as it captures the structural 
        malformations resulting from NEUROG1 loss.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "The boy's internal auditory canal was narrowed and the
            cochlea was hypoplastic with only one single widened cochlear turn"

# Cochlea development and morphogenesis
  - term:
      id: GO:0090102
      label: cochlea development
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Cochlea development defects in NEUROG1-deleted patient.
      action: ACCEPT
      reason: Specific cochlear malformations documented. Acceptable as more 
        specific characterization of inner ear phenotype.
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: "the cochlea was hypoplastic with only one single widened
            cochlear turn"

  - term:
      id: GO:0090103
      label: cochlea morphogenesis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Cochlea morphogenesis defects showing structural malformations.
      action: ACCEPT
      reason: Captures specific morphogenetic defects in cochlear structure. 
        Supported by anatomical descriptions.

## Behavioral and physiological phenotypes from PMID:23419067
# These are secondary consequences of cranial nerve defects

# Auditory behavior
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0031223
      label: auditory behavior
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Profound deafness and auditory defects in NEUROG1 deletion 
        patient.
      action: KEEP_AS_NON_CORE
      reason: The deafness is a secondary consequence of CN VIII aplasia and 
        inner ear malformation, not a direct function of NEUROG1. NEUROG1's core
        function is neuronal specification in the otic placode; the auditory 
        behavior defect is a downstream phenotypic consequence. Mark as non-core
        to distinguish developmental function from behavioral outcome.

# Balance/vestibular function
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0050885
      label: neuromuscular process controlling balance
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Balance disorder in patient due to vestibular nerve and inner ear
        defects.
      action: KEEP_AS_NON_CORE
      reason: Balance defects are secondary to vestibular apparatus and nerve 
        malformation, not a direct developmental function of NEUROG1. The core 
        function is sensory neuron specification; balance impairment is a 
        downstream consequence.

# Oral motor and feeding functions
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0071626
      label: mastication
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Chewing dysfunction in patient with oral motor defects.
      action: KEEP_AS_NON_CORE
      reason: Mastication defects are secondary to trigeminal nerve (CN V) 
        malfunction. While documented in the patient, this is a 
        behavioral/physiological consequence, not a core developmental function 
        of NEUROG1.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0030432
      label: peristalsis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Swallowing difficulties suggesting esophageal dysfunction.
      action: KEEP_AS_NON_CORE
      reason: Peristalsis defects are tertiary consequences of cranial nerve 
        dysfunction affecting swallowing. This is quite removed from NEUROG1's 
        core developmental function. Mark as non-core.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:1905747
      label: negative regulation of saliva secretion
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Increased salivation noted in patient, but annotation logic is 
        unclear.
      action: REMOVE
      reason: The patient had INCREASED salivation, not decreased saliva 
        secretion. This annotation appears to be incorrect or represents a 
        confusing inference. The increased salivation is likely secondary to 
        swallowing difficulty, not a direct regulatory function of NEUROG1. 
        Remove as likely erroneous annotation.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:1901078
      label: negative regulation of relaxation of muscle
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Unclear annotation - may relate to muscle tone abnormalities.
      action: MARK_AS_OVER_ANNOTATED
      reason: This is a very specific and indirect annotation. While the patient
        had various motor abnormalities, attributing "negative regulation of 
        relaxation of muscle" to NEUROG1 is a stretch. This represents 
        over-annotation of tertiary phenotypic consequences. Mark as 
        over-annotated.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0048634
      label: regulation of muscle organ development
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Muscle-related phenotypes possibly from denervation.
      action: MARK_AS_OVER_ANNOTATED
      reason: Any muscle development defects would be secondary to lack of motor
        innervation from cranial nerves, not a direct role of NEUROG1 in muscle 
        development. This represents over-annotation. NEUROG1 specifies neurons,
        not muscle cells.

# Craniofacial and skeletal phenotypes
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0097094
      label: craniofacial suture morphogenesis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Craniofacial abnormalities (scaphocephaly, plagiocephaly) noted 
        in patient.
      action: MARK_AS_OVER_ANNOTATED
      reason: The craniofacial suture abnormalities are likely secondary 
        consequences of developmental disruption or mechanical factors, not a 
        direct role of NEUROG1 in craniofacial morphogenesis. NEUROG1's 
        expression is in neural tissues, not mesenchymal/skeletal elements. 
        Over-annotation.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:1905748
      label: hard palate morphogenesis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: High narrow palate observed in patient.
      action: MARK_AS_OVER_ANNOTATED
      reason: Palate morphology defects are not plausibly direct functions of 
        NEUROG1, which acts in neural tissue specification. These may be 
        secondary effects or unrelated features. Over-annotation.

# Vocalization
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0098583
      label: learned vocalization behavior
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Speech difficulties noted in patient.
      action: KEEP_AS_NON_CORE
      reason: Speech difficulties are plausible secondary consequences of oral 
        motor dysfunction (CN V, CN VII territories) and hearing loss. However, 
        this is a complex behavioral outcome far removed from NEUROG1's core 
        developmental function. Keep as non-core documentation of patient 
        phenotype.

# Genitalia development
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0048806
      label: genitalia development
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Hypoplastic genitalia noted in patient.
      action: MARK_AS_OVER_ANNOTATED
      reason: Hypoplastic genitalia in the patient is unlikely to be a direct 
        consequence of NEUROG1 loss. NEUROG1 is not known to have roles in 
        genitourinary development. This may represent a contiguous gene deletion
        effect (two other genes were deleted), a separate syndrome, or an 
        unrelated finding. Clear over-annotation.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0035112
      label: genitalia morphogenesis
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Hypoplastic genitalia morphology.
      action: MARK_AS_OVER_ANNOTATED
      reason: Same issue as GO:0048806. Not a plausible direct function of 
        NEUROG1. Over-annotation.

# Body plan/patterning - highly questionable
      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
  - term:
      id: GO:0007356
      label: thorax and anterior abdomen determination
    evidence_type: IGI
    original_reference_id: PMID:23419067
    review:
      summary: Unclear how this annotation relates to NEUROG1 function or 
        patient phenotype.
      action: REMOVE
      reason: This annotation makes no biological sense for NEUROG1. The gene is
        a proneural bHLH factor involved in neuronal specification, not in 
        anteroposterior body plan patterning. This appears to be an erroneous 
        automated annotation. Remove.

      supported_by:
        - reference_id: PMID:23419067
          supporting_text: A boy with homozygous microdeletion of NEUROG1 
            presents with a congenital cranial dysinnervation disorder
core_functions:
  - description: Core molecular function as RNA polymerase II-specific 
      transcription factor
    molecular_function:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    directly_involved_in:
      - id: GO:0045666
        label: positive regulation of neuron differentiation
      - id: GO:0021559
        label: trigeminal nerve development
      - id: GO:0021650
        label: vestibulocochlear nerve formation
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0000785
        label: chromatin

  - description: E-box DNA binding activity driving neuronal differentiation
    molecular_function:
      id: GO:0070888
      label: E-box binding
    directly_involved_in:
      - id: GO:0045666
        label: positive regulation of neuron differentiation
      - id: GO:0007423
        label: sensory organ development

proposed_new_terms:
  - proposed_name: negative regulation of glial cell differentiation
    proposed_definition: Any process that stops, prevents, or reduces the 
      frequency, rate or extent of glial cell differentiation.
    justification: NEUROG1 is a proneural factor that promotes neuronal over 
      glial fate. Like other proneural bHLH factors (ASCL1), NEUROG1 actively 
      suppresses gliogenesis. This reciprocal regulation of the neuron-glia fate
      decision is a core function but not currently annotated.
    proposed_parent:
      id: GO:0010771
      label: negative regulation of cell morphogenesis involved in 
        differentiation
    supported_by:
      - reference_id: PMID:8816493
        supporting_text: Inferred from role as proneural factor and parallel to 
          ASCL1 function in suppressing gliogenesis. Proneural bHLH factors 
          characteristically inhibit glial fate as part of neuron-glia binary 
          decision.

  - proposed_name: glutamatergic neuron fate commitment
    proposed_definition: The commitment of neuroblasts to a glutamatergic neuron
      fate and their capacity to differentiate into glutamatergic neurons.
    justification: NEUROG1 specifically promotes glutamatergic (excitatory) 
      neuron fate in the cortex, as opposed to GABAergic fate promoted by 
      ASCL1/DLX factors. This neurotransmitter phenotype specification is a key 
      aspect of NEUROG1's function but is not captured in current annotations.
    proposed_parent:
      id: GO:0048663
      label: neuron fate commitment

references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms
    findings:
      - statement: Used for protein dimerization activity annotation based on 
          bHLH domain (IPR011598, IPR036638)
  - id: GO_REF:0000024
    title: Manual transfer of experimentally-verified manual GO annotation data 
      to orthologs by curator judgment of sequence similarity
    findings:
      - statement: Used for ISS annotations transferred from mouse Neurog1 
          ortholog (P70660)
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings:
      - statement: Used for IBA annotations across neurogenin family members
      - statement: Includes annotations for transcription factor activity, E-box
          binding, neural development processes
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings:
      - statement: Source of broad annotations (DNA binding, nervous system 
          development, cell differentiation, neuron differentiation)
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
      Location vocabulary mapping
    findings:
      - statement: Source of nucleus localization annotation
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara
    findings:
      - statement: Source of mouse orthology-based annotations via Ensembl
      - statement: Includes chromatin binding, neuronal cell body localization, 
          positive regulation annotations
  - id: GO_REF:0000113
    title: Gene Ontology annotation of human sequence-specific DNA binding 
      transcription factors based on TFClass database
    findings:
      - statement: Classifies NEUROG1 as class 1.2.3 bHLH transcription factor 
          (tfclass:1.2.3)
      - statement: Source of ISA evidence for TF activity and chromatin 
          localization
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning
      models
    findings:
      - statement: Source of sequence-specific double-stranded DNA binding 
          annotation
  - id: PMID:20102160
    title: The basic helix-loop-helix region of human neurogenin 1 is a 
      monomeric natively unfolded protein which forms a "fuzzy" complex upon DNA
      binding
    findings:
      - statement: Demonstrates NEUROG1 bHLH domain is natively unfolded and 
          forms partially structured complexes upon E-box DNA binding
      - statement: Shows NEUROG1 can form homodimers and bind DNA, though with 
          lower affinity than other bHLH proteins
      - statement: Provides direct experimental evidence (IDA, EXP) for DNA 
          binding, E-box binding, and homodimerization activities
  - id: PMID:23419067
    title: A boy with homozygous microdeletion of NEUROG1 presents with a 
      congenital cranial dysinnervation disorder
    findings:
      - statement: First report of human NEUROG1 deletion phenotype
      - statement: Patient shows profound deafness due to CN VIII aplasia, oral 
          motor dysfunction due to CN V defects
      - statement: Inner ear malformations including cochlear hypoplasia (1 turn
          instead of 2.5), narrow internal auditory canal
      - statement: Balance disorder, feeding difficulties, speech delay, 
          developmental delay
      - statement: Phenotype matches neurog1 knockout mice perfectly, 
          establishing NEUROG1 as essential for proximal cranial sensory neuron 
          development (CN V, CN VIII from trigeminal and otic placodes)
      - statement: Source of genetic interaction (IGI) evidence for cranial 
          nerve and sensory organ development annotations
  - id: PMID:25416956
    title: A proteome-scale map of the human interactome network
    findings:
      - statement: Proteome-scale interaction study identifying NEUROG1-TCF4 
          interaction
      - statement: Source of protein binding (IPI) annotation - marked for 
          removal per guidelines
  - id: PMID:28473536
    title: Impact of cytosine methylation on DNA binding specificities of human 
      transcription factors
    findings:
      - statement: Systematic study of TF DNA-binding specificities in context 
          of DNA methylation
      - statement: Source of IDA evidence for sequence-specific DNA binding
  - id: PMID:32296183
    title: A reference map of the human binary protein interactome
    findings:
      - statement: Large-scale binary interactome study
      - statement: Source of protein binding annotation (marked for removal)
  - id: PMID:32814053
    title: Interactome Mapping Provides a Network of Neurodegenerative Disease 
      Proteins and Uncovers Widespread Protein Aggregation in Affected Brains
    findings:
      - statement: Neurodegenerative disease interactome study
      - statement: Source of protein binding annotations (marked for removal)
  - id: PMID:33961781
    title: Dual proteome-scale networks reveal cell-specific remodeling of the 
      human interactome
    findings:
      - statement: Cell-specific interactome remodeling study
      - statement: Source of protein binding annotation (marked for removal)
  - id: PMID:40205054
    title: Multimodal cell maps as a foundation for structural and functional 
      genomics
    findings:
      - statement: Multimodal cell atlas study
      - statement: Source of protein binding annotation (marked for removal)
  - id: PMID:8816493
    title: NeuroD2 and neuroD3 - distinct expression patterns and 
      transcriptional activation potentials within the neuroD gene family
    findings:
      - statement: Original characterization of NEUROG1 (neuroD3) gene family 
          member
      - statement: Shows NEUROG1 expressed transiently during embryonic 
          development (E10-12 in mouse)
      - statement: Demonstrates neurogenic activity in Xenopus - ectopic 
          neurogenesis when expressed
      - statement: Shows NEUROG1 can activate E-box-driven reporters in P19 
          cells
      - statement: Establishes NEUROG1 as a proneural bHLH transcription factor
      - statement: Source of TAS evidence for transcription factor activity and 
          nervous system development
  - id: file:human/NEUROG1/NEUROG1-deep-research-falcon.md
    title: Deep research report on NEUROG1
    findings: []

NEUROG1

Gene Description

Proposed New Ontology Terms

negative regulation of glial cell differentiation

glutamatergic neuron fate commitment

Existing Annotations Review

Core Functions

Core molecular function as RNA polymerase II-specific transcription factor

E-box DNA binding activity driving neuronal differentiation

References

📚 Additional Documentation

Deep Research Falcon

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Output

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Citations

📄 View Raw YAML